Vertex Pharmaceuticals Incorporated

NASDAQ:VRTX

494.61 (USD) • At close November 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996199519941993199219911990
Revenue 9,869.28,930.77,574.46,205.6834,162.8213,047.5972,488.6521,702.1771,032.336580.4151,211.9751,527.0421,410.626143.37102.049175.504199.012216.356160.89102.71769.141161.085167.4978.12761.644.443.813.322.119.627.93.83.22.3
Cost of Revenue 1,262.21,080.3904.2736.3547.758409.539275.119210.46125.54260.987130.277279.88580.50512.7314.20215.68613.90412.1710.0985.6493.12628.28139.6294.082-3.4-4.5-3.6-3.2-3.7-3.5-3.9-2.8-1.80
Gross Profit 8,6077,850.46,670.25,469.3833,615.0632,638.0582,213.5331,491.717906.794519.4281,081.6981,247.1571,330.121130.6487.847159.818185.108204.186150.79297.06866.015132.804127.86174.0456548.947.416.525.823.131.86.652.3
Gross Profit Ratio 0.8720.8790.8810.8810.8680.8660.8890.8760.8780.8950.8930.8170.9430.9110.8610.9110.930.9440.9370.9450.9550.8240.7630.9481.0551.1011.0821.2411.1671.1791.141.7371.5631
Reseach & Development Expenses 3,162.92,540.33,051.11,829.5371,754.541,416.4761,324.6251,047.69996.17855.506918.783806.185707.706637.416550.685516.292513.054371.713248.54192.162199.636203.018148.67384.92172.258.751.635.241.500000
General & Administrative Expenses 0000000401.429352.58289.209342.742378.1960000000000000000000000
Selling & Marketing Expenses 000000031.424.516.219.658.60000000000000000000000
SG&A 1,136.6944.7840.1770.456658.498557.616496.079432.829377.08305.409362.342436.796400.721187.8129.297101.9184.72757.8643.9942.13939.08249.3947.33727.80626.118.111.47.97.140.326.713.88.86.4
Other Expenses 475.5-164.84.9296.42192.177-0.79-81.3824.13-6.71330.4-72.66944.987124.754000000000006.34.53.63.23.73.53.92.81.80
Operating Expenses 4,7753,4853,891.22,599.9932,413.0381,974.0921,820.7041,480.5191,373.251,160.9151,281.1251,242.9811,108.427825.216679.982618.202597.781429.573292.53234.301238.718252.408196.01112.727104.681.366.646.352.343.830.616.610.66.4
Operating Income 4,307.54,307.42,782.12,856.291,197.566635.15123.2439.936-468.662-692.412-903.4482.332113.82-696.077-613.412-462.708-419.792-229.038-149.872-154.807-264.527-119.604-91.803-38.682-39.6-32.4-19.2-29.8-26.5-20.71.2-10-5.6-4.1
Operating Income Ratio 0.4360.4820.3670.460.2880.2080.050.006-0.454-1.193-0.7450.0020.081-4.855-6.011-2.636-2.109-1.059-0.932-1.507-3.826-0.742-0.548-0.495-0.643-0.73-0.438-2.241-1.199-1.0560.043-2.632-1.75-1.783
Total Other Income Expenses Net 72.3-75-51.762.798197.419-34.909-138.932-77.302-90.921-42.463-366.109-59.108-53.375-58.549-28.1662.85728.51321.101-53.545-11.4467.7628.299-2.789-16.16410.30005.53.60.920.84.1
Income Before Tax 4,379.84,232.42,730.43,116.7981,394.919600.241-15.689-67.366-559.581-734.875-976.117-12.38160.445-754.626-642.178-464.175-426.911-206.891-173.39-158.505-347.349-119.659-117.89-53.607-40.300-39.5-21-17.12.1-8-4.80
Income Before Tax Ratio 0.4440.4740.360.5020.3350.197-0.006-0.04-0.542-1.266-0.805-0.0080.043-5.263-6.293-2.645-2.145-0.956-1.078-1.543-5.024-0.743-0.704-0.686-0.65400-2.97-0.95-0.8720.075-2.105-1.50
Income Tax Expense 760.2910.4388.3405.151218.109-1,486.862-107.32416.66530.3816.958-288.56738.75419.26619.27519.336-30.729-21.394-18.49661.67929.01424.064-10.983-1.9160.9761.40.70.610.2-5-3.10.1-1.5-0.54.3
Net Income 3,619.63,3222,342.12,711.71,176.812,096.896263.484-112.052-558.115-738.555-445.028-107.03229.574-754.626-641.578-459.851-391.279-206.891-203.417-166.247-196.767-108.621-66.233-39.658-41-33.1-19.8-40-21.5-17.62-8.5-5.1-4.3
Net Income Ratio 0.3670.3720.3090.4370.2830.6880.106-0.066-0.541-1.272-0.367-0.070.021-5.263-6.287-2.62-1.966-0.956-1.264-1.618-2.846-0.674-0.395-0.508-0.666-0.745-0.452-3.008-0.973-0.8980.072-2.237-1.594-1.87
EPS 14.0512.979.0910.444.588.251.06-0.46-2.32-3.14-1.98-0.50.14-3.77-3.7-3.27-3.03-1.83-2.28-2.12-2.56-1.43-0.89-0.59-0.8-0.65-0.41-1.07-0.63-0.560.08-0.35-0.35-0.33
EPS Diluted 13.8912.829.0110.294.518.091.04-0.46-2.31-3.14-1.98-0.50.14-3.77-3.7-3.27-3.03-1.83-2.28-2.12-2.56-1.43-0.89-0.59-0.8-0.65-0.41-1.07-0.63-0.560.08-0.35-0.35-0.33
EBITDA 4,605.24,435.52,917.53,284.4641,560.362706.78103.25875.464-411.251-598.755-554.75342.463133.938-704.892-598.879-426.188-385.214-199.519-114.449-107.593-264.527-123.053-97.137-24.651-44.3-43.2-15.6-36.3-22.8-17.25.1-7.2-3.8-4.1
EBITDA Ratio 0.4670.4870.3680.5140.350.2180.1250.009-0.458-1.0530.4160.0030.157-4.619-5.318-2.603-1.9-0.933-0.565-1.011-0.961-0.584-0.144-0.188-0.529-0.628-0.356-1.271-1.281-1.0610.133-2.421-1.438-1.783